NCT02325492View on ClinicalTrials.gov

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Gallstones
Interventions
DRUG

Aramchol

DRUG

Placebo

DEVICE

Ultrasound

Trial Locations (1)

Unknown

Assuta Medical Center, Tel Aviv

Sponsors
All Listed Sponsors
lead

Galmed Pharmaceuticals Ltd

INDUSTRY

NCT02325492 - Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study | Biotech Hunter | Biotech Hunter